Bio-Techne Corp. Stock
Bio-Techne Corp. Stock
The Bio-Techne Corp. stock is trending slightly upwards today, with an increase of €0.18 (0.290%) compared to yesterday's price.
With 18 Buy predictions and not the single Sell prediction the community is currently very high on Bio-Techne Corp..
On the other hand, the target price of 60 € is below the current price of 62.98 € for Bio-Techne Corp., so the potential is actually -4.73%.
So far the community has only identified positive things for Bio-Techne Corp. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Bio-Techne Corp. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
B****
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bio-Techne Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bio-Techne Corp. | 0.290% | -0.095% | 1.287% | 25.960% | 25.960% | -19.256% | - |
| Haemonetics Corp. | 0.720% | 2.985% | 6.977% | - | 0.730% | - | - |
| CONMED Corp. | -0.530% | 0.535% | 22.876% | -10.476% | 7.429% | -65.505% | -66.726% |
| Penumbra Inc | 0.140% | 0.575% | 0.503% | 42.067% | 5.030% | 2.868% | 22.612% |
Comments
Bio-Techne (TECH) was upgraded by Evercore Inc from "hold" to "strong-buy".
Show more
Ratings data for TECH provided by MarketBeat
Bio-Techne (TECH) had its "buy" rating reaffirmed by TD Cowen.
Show more
Ratings data for TECH provided by MarketBeat
Bio-Techne (TECH) had its price target lowered by Citigroup Inc. from $80.00 to $70.00. They now have a "buy" rating on the stock.
Show more
Ratings data for TECH provided by MarketBeat